Study of BHQ880 in Patients With High Risk Smoldering Multiple Myeloma
Clinical trial NCT01302886 · COMPLETED
Trial details
- NCT number
- NCT01302886
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2013-11-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.